Finally, the 11 prognostic SRGs in the final multivariate model were validated by the CGGA data and we found three novel prognostic biomarkers (F2RL2, CLCNKA and LOXL4) for glioma that have not been reported before (Supplementary Figures S2–4). This evidence concerns the gene F2RL2 and central nervous system cancer.